Donepezil-Induced Myoclonus in a Patient With Alzheimer Disease
暂无分享,去创建一个
[1] M. Hashimoto,et al. Efficacy of increasing donepezil in mild to moderate Alzheimer's disease patients who show a diminished response to 5 mg donepezil: a preliminary study , 2013, Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society.
[2] A. Verkhratsky,et al. The serotonergic system in ageing and Alzheimer's disease , 2012, Progress in Neurobiology.
[3] D. Moellentin,et al. Memantine-Induced Myoclonus and Delirium Exacerbated by Trimethoprim , 2008, The Annals of pharmacotherapy.
[4] S. Papageorgiou,et al. Exacerbation of myoclonus by memantine in a patient with Alzheimer disease. , 2007, Journal of clinical psychopharmacology.
[5] A. Lajtha,et al. Changes in cerebral neurotransmitters and metabolites induced by acute donepezil and memantine administrations: A microdialysis study , 2006, Brain Research Bulletin.
[6] B Müller-Oerlinghausen,et al. The AGNP-TDM Expert Group Consensus Guidelines: Therapeutic Drug Monitoring in Psychiatry , 2004, Pharmacopsychiatry.
[7] J. Caviness. Myoclonus and neurodegenerative disease--what's in a name? , 2003, Parkinsonism & related disorders.
[8] S. Tsuji,et al. Amantadine-induced cortical myoclonus , 2001, Neurology.
[9] R. Edwards,et al. Donepezil Overdose: A Tenfold Dosing Error , 1999, The Annals of pharmacotherapy.
[10] R. Mohs,et al. Donepezil improves cognition and global function in Alzheimer disease: a 15-week, double-blind, placebo-controlled study. Donepezil Study Group. , 1998, Archives of internal medicine.
[11] S H Ferris,et al. Diagnosis and treatment of Alzheimer disease and related disorders. Consensus statement of the American Association for Geriatric Psychiatry, the Alzheimer's Association, and the American Geriatrics Society. , 1997, JAMA.
[12] D. Geldmacher. Donepezil (Aricept) therapy for Alzheimer's disease. , 1997, Comprehensive therapy.
[13] D. Morgan. The dopamine and serotonin systems during aging in human and rodent brain. A brief review , 1987, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[14] Y. Ugawa,et al. Myoclonus in Alzheimer's disease , 1987, Journal of Neurology.
[15] D. Greenblatt,et al. A method for estimating the probability of adverse drug reactions , 1981, Clinical pharmacology and therapeutics.
[16] Jin-Tai Yu,et al. Efficacy and safety of donepezil, galantamine, rivastigmine, and memantine for the treatment of Alzheimer's disease: a systematic review and meta-analysis. , 2014, Journal of Alzheimer's disease : JAD.
[17] F. Jiménez-Jiménez,et al. Drug-Induced Myoclonus , 2004, CNS drugs.
[18] Donepezil (Aricept) for Alzheimer's disease. , 1997, The Medical letter on drugs and therapeutics.